Abiopharma

UNIVERSAL INSURANCE HOLDINGS, INC. (UVE) Reports the reporting period Financial Results UNIVERSAL INSURANCE HOLDINGS, INC. (UVE) announced its financial results for the period ending the reporting period. Key Financial Highlights:

• Revenue: 398162
• Net Income: 54291
• EPS: Not disclosed
• Cash and equivalents: 2635
  • anticipated increases in the severity or frequency of claims adversely affect our profitability and financial condition;•the failure of the risk mitigation strategies we utilize could have a material adverse effect on our financial condition or results of operations; and•the risks and uncertainties, as they may be amended from time to time, set forth in our filings with the U.S. Securities and Exchange Commission, including under the heading “Risk Factors” and “Liquidity and Capital Resources” in our most recent Annual Report on Form 10-K, and supplemented in our subsequent Quarterly Reports on Form 10-Q. Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results or outcomes could differ materially from those projected or assumed in any of our forward-looking statements. There may be other factors not presently known to us or which we currently consider to be immaterial that could cause our actual results to differ materially from those projected in any forward-looking statements we make. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. For further information regarding risk factors that could affect the Company’s operations and future results, refer to the Company’s reports filed with the Securities and Exchange Commission, including the Company’s Annual Report on Form 10-K and the most recent quarterly reports on Form 10-Q.Investors/Media:Arash Soleimani, CFA, CPA, CPCU, AReChief Strategy Officer954-804-8874